IDEA
IDEA AG develops and commercializes non-invasive targeted therapeutics applied through the skin for delivery of drugs. The company uses Transfer some carriers for transporting the established molecular weight drugs selectively into the skin. It focuses on dermatological and pain therapeutics. The company’s Diractin is a ketoprofen in the Transfersome gel for the treatment of peripheral pain. IDEA AG was founded in 1993 and is based in Munich, Germany.
IDEA
Industry:
Biotechnology Developer Platform Therapeutics
Founded:
1993-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.idea-ag.de
Total Employee:
1+
Status:
Active
Contact:
+49893246330
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Investors List
More informations about "Idea"
IDEA
We accomplish this by empowering your organization with rigorous program design, field-tested surveys and assessments, regular coaching and consultations, and the sharing of relevant educational resources that will best …See details»
Idea - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +49893246330; IDEA AG develops and commercializes non-invasive targeted therapeutics applied through the skin for delivery of …See details»
IDEA AG Company Profile | München, Bayern, Germany
Find company research, competitor information, contact details & financial data for IDEA AG of München, Bayern. Get the latest business insights from Dun & Bradstreet.See details»
IDEA AG, Munich, Germany - North Data
IDEA AG, Munich, Germany, District Court of Munich HRB 126714: Earnings, Patents, Revenue, Employees, Network, Financial informationSee details»
IDEA AG - Life-Sciences-Europe.com
Jul 18, 1998 IDEA AG. https://www.idea-ag.de. IDEA is a privately held biopharmaceutical company with headquarters in Munich, Germany. The Company develops and commercialises …See details»
IDEA AG, München - Pharmazie - CompanyHouse
IDEA AG in München, Gesellschafter, Management, Netzwerk, Jahresabschlüsse, Bekanntmachungen - Entwicklung, Charakterisierung, Test, Prüfung, Herstellung ...See details»
IDEA AG, München - North Data
IDEA AG, München, Amtsgericht München HRB 126714: Gewinn, Patente, Umsatz, Mitarbeiter, Netzwerk, WirtschaftsinfosSee details»
Organization | IDEA AG - Purdue University
IDEA AG Report issue. For profit Phase 2 Phase 3. Founded: Munich Germany (1993 ... Organization Overview. First Clinical Trial. 2004 NCT00372333. First Marketed Drug. None …See details»
IDEA AG Firmenprofil| München, Bayern, Germany | Mitbewerber ...
IDEA AG Firmenprofil| München, Bayern, Germany | Mitbewerber, Finanzdaten & Ansprechpersonen - Dun & Bradstreet Finden Sie Unternehmensinformationen, Mitbewerber, …See details»
IDEA AG - Ownership and Business Overview - Mergr
Jan 1, 2010 IDEA AG was founded in 1993. Life Science M&A Summary in 2010. ... www.idea-ag.de. Profile Investors (2) Analytics IDEA focused on non-invasive topical delivery of …See details»
Idea Ag - München 80636 (München), Arnulfstraße 39 ... - Kompass
IDEA AG develops therapeutics using self-optimising carriers for targeted and non-invasive delivery of drugs, including proteins. ... (DE 2008) : Technische, physikalische und chemische …See details»
IDEA AG - Company Profile and News - Bloomberg Markets
IDEA AG provides bio-pharmaceutical products and research. The Company offers non-invasive therapies for skin related illnesses, as well as pain therapeutics. IDEA serves customer …See details»
IDEA Company Profile - Office Locations, Competitors, Revenue
IDEA is a biopharmaceutical company focused on the area of dermatology and pain. It develops and commercialises non-invasive, targeted therapeutics based on stable, ultra-deformable …See details»
IDEA AG - Life-Sciences-Europe.com
Jul 18, 1998 Upcoming Events. BIO-Europe 2024 Stockholm; PEGS Europe 2024 Barcelona; UBS Global Healthcare Conference 2024 Rancho Palos Verdes; Guggenheim Global …See details»
Idea AG - Products, Competitors, Financials, Employees, …
Idea AG. Frequently Asked Questions (FAQ) What is Idea AG's latest funding round? Idea AG's latest funding round is Corporate Minority. How much did Idea AG raise? Idea AG raised a …See details»
Idea Company Profile 2024: Valuation, Funding & Investors
Idea General Information Description. Operator of a biopharmaceutical company committed to develop and commercialize non-invasive and targeted therapeutics. The company's …See details»
IDEA AG - Company Profile - Tracxn
Nov 15, 2024 IDEA AG - Developed transfersomes for transdermal drug delivery. Raised funding over 1 round from 4 investors. IDEA AG has 2756 competitors. ... Email ID: …See details»
Partners - IDEA
Who IDEA works with around the world. LiveBeyondSee details»
Idea AG - BioCentury Company Profiles - BCIQ
May 10, 2010 Idea AG - BioCentury Company Profiles for the biopharma industrySee details»
Harvesting Impact Masterclass | IDEA
In 2013, David founded IDEA (International Development Extension Agency) where he empowers INGOs and Ministries of Agriculture with his expertise in agricultural development. His …See details»